immunologically's Usage Examples:

Initially, it was thought to prove that the brain was an immunologically privileged organ, as the host's immune system did not attack it at.

It is associated with hypomorphic missense mutations in immunologically relevant genes of T-cells (and B-cells) such as recombination activating.

relative) means genetically identical, or sufficiently identical and immunologically compatible as to allow for transplantation.

The condition is thought to be an immunologically induced disease in which elevated level of testosterone causes a rise.

(TA-GvHD) is a rare complication of blood transfusion, in which the immunologically competent donor T lymphocytes mount an immune response against the.

virus (CAEV) is a retrovirus which infects goats and cross-reacts immunologically with HIV, due to being from the same family of viruses.

during outbreaks were usually extremely high, approaching 100% in immunologically naïve populations.

(European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders.

PIOL and PCNSL remain enigmas because both structures are immunologically privileged sites (the brain sits behind the blood–brain barrier and.

The cornea of the eye is immunologically a very special tissue.

species that naturally harbour the viruses into new areas, exposing immunologically susceptible populations.

opportunistic fungal pathogen that causes a wide variety of infections in immunologically normal and immunosuppressed people and animals.

twins in human or of the same pure line in experimental animals from immunologically sensitized to naive host, where transferred cells are engrafted without.

system of some susceptible individuals produces antibodies that react immunologically with these antigenic proteins.

finding of normal immunologically-detected levels of fibrinogen in congenital dysfibrinogenemia and sub-normal levels of immunologically-detected fibrinogen.

glycoprotein initially identified as a target of antibodies in some forms of immunologically mediated tubulointerstitial nephritis.

They were founded in 1953 to develop immunologically-based treatments for cancer, and despite their name are a funding body.